Trial · NCT06012760
The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
NCT06012760, Not applicable, Recruiting, Second Affiliated Hospital, Zhejiang University, School of Medicine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion. Trials, record NCT06012760. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06012760
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
- NCT number
- NCT06012760
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 400 participants, estimated
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Conditions
- Anemia, Iron Deficiency Anemia, Perioperative, Transfusion, Cardiac Surgery
- Interventions
- Iron sucrose, Human Erythropoietin Injection, Vitamin C, Standard Medical Care
- First posted
- 2023-08-25
- Last updated
- 2026-06-02
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Perioperative allogeneic red blood cell transfusion volume | From the initiation of the surgical procedure until five days post-surgery. | The volume of allogeneic red blood cell transfusions during the perioperative period. |
| Secondary | The quantity and percentage of allogeneic blood products utilized during the perioperative period. | From the initiation of the surgical procedure until until 90± 7 days following the surgical procedure. | This encompasses blood components such as plasma and platelets, erythrocytes. |
| Secondary | The alterations in perioperative haemoglobin levels. | From the point of randomisation until 90± 7 days following the surgical procedure. | Haemoglobin levels were assessed at various time intervals. |
| Secondary | The alterations in ferritin levels and TSAT during the perioperative period. | From the point of randomisation until 90± 7 days following the surgical procedure. | Ferritin and Transferrin Saturation values were assessed at various time intervals. |
| Secondary | The alterations in reticulocyte levels during the perioperative period. | From the point of randomisation until 90± 7 days following the surgical procedure. | Reticulocyte levels were measured at various time intervals. |
| Secondary | The score measuring the quality of life after surgery. | From the point of randomisation until 90± 7 days following the surgical procedure. | The findings are presented based on the EQ VAS score (0-100), which reflects the overall self-assessed health status. A higher score indicates a better health status. Additionally, the results are reported using the EQ-5D-3L Effectiveness Index (EQ-5D-3L) values (5-15), where a lower EQ-5D-3L value signifies a better state of health. |
| Secondary | Incidence of perioperative complication within 90 days after major cardiac surgery | From the point of randomisation until 90± 7 days following the surgical procedure. | The potential postoperative complications within acute kidney injury (AKI), serious adverse events (SAE), congestive heart failure, respiratory failure, Allergic reaction, Thrombotic and thromboembolic complications and various infections. |
| Secondary | The mortality rate within 30-day and 90-day postoperative period. | Within 90± 7 days after surgery | The mortality rate within 30-day and 90-day postoperative period. |
| Secondary | length of stay in hospital | Within 90± 7 days after surgery | The time period from admission to the hospital to discharge |
| Secondary | Length of stay in ICU | Within 90± 7 days after surgery | The time period from admission to ICU after surgery to move out from ICU to normal ward |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06012760
GET https://conductscience.org/api/trials/v1/NCT06012760/registered